Experts from the American Institutes for Research to Present at the 2024 AcademyHealth Annual Research Meeting
24 juin 2024 11h45 HE
|
American Institutes for Research
Arlington, Va., June 24, 2024 (GLOBE NEWSWIRE) -- Experts from the American Institutes for Research (AIR) will present several posters about their health research work at the upcoming Academy Health...
Pandemic stress in pregnant mothers may affect anxiety regions of babies’ brains
20 juin 2024 12h41 HE
|
Children's National Hospital
Washington, D.C., June 20, 2024 (GLOBE NEWSWIRE) -- A critical part of the brain linked to risks for anxiety later in life – the left amygdala – was significantly smaller by volume in babies of...
Raydiant Oximetry Oversubscribes Series A $7.5 Million Extension Round
04 juin 2024 09h00 HE
|
Raydiant Oximetry
Raydiant Oximetry, a clinical-stage medical device company, has oversubscribed a $7.5 million Series A3 extension round.
Frontier Nursing University and Campion Fund to Host Maternal Mortality Conference
22 mai 2024 08h09 HE
|
Frontier Nursing University
Versailles, Ky, May 22, 2024 (GLOBE NEWSWIRE) -- Frontier Nursing University (FNU) and the Campion Fund announced plans for a conference focused on the nation’s maternal mortality crisis. “Reducing...
SimpliFed Works with EmblemHealth to Support New Parents
01 mai 2024 08h10 HE
|
SimpliFed
ITHACA, NY; NEW YORK, NY, May 01, 2024 (GLOBE NEWSWIRE) -- SimpliFed, a virtual maternal health leader in lactation support, and EmblemHealth, one of the nation’s largest nonprofit health insurers,...
Poll: More Than Half of Black Birthers in Minnesota Feel Racial Bias and Lack of Access Leads to Greater Health Risks and Maternal Mortality
11 avr. 2024 08h00 HE
|
Blue Cross and Blue Shield of Minnesota
New poll by BCBS MN finds more than half of Black Minnesota birthers feel that discrimination based on their race/ethnicity negatively impacts their health
Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
10 avr. 2024 12h04 HE
|
Raydiant Oximetry
The FDA has approved the Investigational Device Exemption (IDE) of Lumerah for an Early Feasibility Study (EFS) of pregnant women during labor and delivery
The National Women’s Health Network Releases 2024 Policy Agenda
24 janv. 2024 12h23 HE
|
National Women's Health Network
Washington, D.C., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Women comprise more than half of the United States population, and yet women are far less likely to have access to health care and more likely to...
Meet Five Community-Based Reproductive Justice Organizations Who Will Take the National Stage This Year
23 janv. 2024 14h14 HE
|
National Women's Health Network
Washington, D.C., Jan. 23, 2024 (GLOBE NEWSWIRE) -- The National Women’s Health Network (NWHN), based in Washington, D.C., launched the second annual Health Equity & Access Leadership Training...
Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia
17 janv. 2024 06h00 HE
|
Comanche Biopharma
Comanche Biopharma closes oversubscribed $75 Million Series B financing to advance first treatment targeting a root cause of preeclampsia.